CARA
Cara Therapeutics Inc
Price:  
0.27 
USD
Volume:  
313,148.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CARA WACC - Weighted Average Cost of Capital

The WACC of Cara Therapeutics Inc (CARA) is 6.0%.

The Cost of Equity of Cara Therapeutics Inc (CARA) is 8.35%.
The Cost of Debt of Cara Therapeutics Inc (CARA) is 5.00%.

Range Selected
Cost of equity 5.50% - 11.20% 8.35%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.6% - 7.4% 6.0%
WACC

CARA WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.36 1.13
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.50% 11.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.6% 7.4%
Selected WACC 6.0%